Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors.
Brissot
E
E
Chevallier
P
P
Guillaume
T
T
Delaunay
J
J
Ayari
S
S
Dubruille
V
V
Le Gouill
S
S
Mahe
B
B
Gastinne
T
T
Blin
N
N
Saulquin
B
B
Flandrois
G
G
Devys
A
A
Stocco
V
V
Cesbron
A
A
Dehaut
F
F
Moreau
P
P
Harousseau
J-L
JL
Mohty
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018952:Antigens, CD34 / Q000097:blood; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage* / Q000009:adverse effects; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D007937:Leukapheresis / Q000379:methods; D008297:Male; D008875:Middle Aged; D014019:Tissue Donors; D019172:Transplantation Conditioning; D016896:Treatment Outcome; D055815:Young Adult
D018952:Antigens, CD34; D016179:Granulocyte Colony-Stimulating Factor